Condition
Genitourinary Disease
Total Trials
6
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 4 (1)
Trial Status
Completed2
Terminated1
Unknown1
Enrolling By Invitation1
Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06421103Not ApplicableRecruiting
Micro-dosing Indocyanine Green (ICG) in Children
NCT03996603Phase 4Completed
Investigation of Microbiomes of Postmenopausal Women Looking for Outcomes and Response to Estrogen Therapy
NCT05889806Enrolling By Invitation
AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)
NCT03956563Not ApplicableUnknown
Effect of Hybrid Laser 10600+1540 nm on GSM
NCT00912912Phase 2TerminatedPrimary
Sunitinib Malate in Refractory Germ Cell Tumors
NCT01896076Completed
The Caudal Space in Children: Ultrasound Evaluation
Showing all 6 trials